Through analysis of publicly available transcriptomic data and bioinformatics, differential gene expression profiles in individuals with scleroderma, lupus erythematosus, and SS revealed the PI3K/Akt pathway as the most frequently enriched pathway [184]. This evidence concerns the gene AKT1 and synovial sarcoma.